Spots Global Cancer Trial Database for stage iv prostate cancer ajcc v7

Every month we try and update this database with for stage iv prostate cancer ajcc v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer	NCT02522715	Castration-Resi... Metastatic Pros... Recurrent Prost... Stage IV Prosta...	Cabazitaxel Enzalutamide Laboratory Biom... Pharmacological... Prednisone	18 Years -	OHSU Knight Cancer Institute
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer	NCT03448458	Castration-Resi... Metastatic Pros... Stage IV Prosta...	CT (Computed To... Gallium Ga 68-D... Positron Emissi...	18 Years -	Emory University
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer	NCT01576172	Castration-Resi... Recurrent Prost... Stage IV Prosta...	Abiraterone Ace... Laboratory Biom... Prednisone Veliparib	18 Years -	National Cancer Institute (NCI)
Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer	NCT02565901	Castration-Resi... Metastatic Pros... Stage IV Prosta... Metastatic Mali...	Carboplatin Docetaxel Laboratory Biom... Sirolimus	18 Years -	University of Washington
Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer	NCT02565901	Castration-Resi... Metastatic Pros... Stage IV Prosta... Metastatic Mali...	Carboplatin Docetaxel Laboratory Biom... Sirolimus	18 Years -	University of Washington
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer	NCT01576172	Castration-Resi... Recurrent Prost... Stage IV Prosta...	Abiraterone Ace... Laboratory Biom... Prednisone Veliparib	18 Years -	National Cancer Institute (NCI)
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer	NCT03448458	Castration-Resi... Metastatic Pros... Stage IV Prosta...	CT (Computed To... Gallium Ga 68-D... Positron Emissi...	18 Years -	Emory University
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer	NCT01050504	Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta...	Cytology Specim... Laboratory Biom...	18 Years -	University of Washington
68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery	NCT03368547	Prostate Adenoc... Stage IIB Prost... Stage III Prost... Stage IV Prosta...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	-	Jonsson Comprehensive Cancer Center
Fatigue Interventions in Cancer (Exercise Intervention)	NCT03421782	Sedentary Lifes... Stage III Prost... Stage IV Prosta...	Cognitive Behav... Exercise Interv...	-	University of Utah
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer	NCT00064129	Recurrent Prost... Stage IV Prosta...	Ipilimumab Laboratory Biom... Pharmacological... Sargramostim	18 Years -	National Cancer Institute (NCI)
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer	NCT00064129	Recurrent Prost... Stage IV Prosta...	Ipilimumab Laboratory Biom... Pharmacological... Sargramostim	18 Years -	National Cancer Institute (NCI)
Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer	NCT02565901	Castration-Resi... Metastatic Pros... Stage IV Prosta... Metastatic Mali...	Carboplatin Docetaxel Laboratory Biom... Sirolimus	18 Years -	University of Washington
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer	NCT01050504	Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta...	Cytology Specim... Laboratory Biom...	18 Years -	University of Washington
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer	NCT01050504	Localized Renal... Malignant Solid... Metastatic Mali... Metastatic Mali... Metastatic Rena... Recurrent Bladd... Recurrent Prost... Recurrent Renal... Stage IV Bladde... Stage IV Bladde... Stage IV Prosta...	Cytology Specim... Laboratory Biom...	18 Years -	University of Washington
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer	NCT01576172	Castration-Resi... Recurrent Prost... Stage IV Prosta...	Abiraterone Ace... Laboratory Biom... Prednisone Veliparib	18 Years -	National Cancer Institute (NCI)
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer	NCT00942331	Advanced Urothe... Metastatic Blad... Metastatic Pros... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Stage IV Bladde... Stage IV Prosta... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Unresectable Ur...	Bevacizumab Cisplatin Gemcitabine Hyd... Laboratory Biom... Placebo Adminis...	18 Years -	National Cancer Institute (NCI)
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer	NCT00064129	Recurrent Prost... Stage IV Prosta...	Ipilimumab Laboratory Biom... Pharmacological... Sargramostim	18 Years -	National Cancer Institute (NCI)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection	NCT05334069	Acute Lymphobla... Acute Myeloid L... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Chronic Lymphoc... Chronic Myeloid... Gastroesophagea... Head and Neck C... Hematopoietic a... Invasive Breast... Kidney Carcinom... Malignant Hepat... Malignant Solid... Melanoma Muscle-Invasive... RISS Stage I Pl... RISS Stage II P... RISS Stage III ... Sarcoma Stage I Bladder... Stage I Breast ... Stage I Colorec... Stage I Esophag... Stage I Gastric... Stage I Lung Ca... Stage I Ovarian... Stage I Pancrea... Stage I Prostat... Stage I Uterine... Stage II Bladde... Stage II Breast... Stage II Colore... Stage II Esopha... Stage II Gastri... Stage II Lung C... Stage II Ovaria... Stage II Pancre... Stage II Prosta... Stage II Uterin... Stage III Bladd... Stage III Breas... Stage III Color... Stage III Esoph... Stage III Gastr... Stage III Lung ... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage III Uteri... Stage IV Bladde... Stage IV Breast... Stage IV Colore... Stage IV Esopha... Stage IV Gastri... Stage IV Lung C... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Uterin... Thyroid Gland C...	Questionnaire A... Biospecimen Col...	40 Years - 75 Years	Alliance for Clinical Trials in Oncology
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer	NCT01480154	Advanced Malign... Stage III Cutan... Stage III Prost... Stage III Renal... Stage IIIA Cuta... Stage IIIB Cuta... Stage IIIC Cuta... Stage IV Cutane... Stage IV Prosta... Stage IV Renal ...	Akt Inhibitor M... Hydroxychloroqu...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: